Eric X Chen (Eric Chen)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Topics

Metastatic Colorectal Cancer

Circulating Tumor

Top Venues

Journal for immunotherapy of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Current oncology (Toronto, Ont.)

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yvonne W Leung, Enid W Y Kwong, Karen Lok Yi Wong, Jeremiah So, Frankie Poon, Terry Cheng, Eric X Chen, Alex Molassiotis, Doris Howell
Understanding Elderly Chinese Cancer Patients in a Multicultural Clinical Setting: Embracing Mortality and Addressing Misperceptions of Vulnerability. Current oncology (Toronto, Ont.) 31 (5) (2024)
Yvonne W Leung, Enid W Y Kwong, Karen Lok Yi Wong, Jeremiah So, Frankie Poon, Terry Cheng, Eric X Chen, Alex Molassiotis, Doris Howell
Understanding Elderly Chinese Cancer Patients in a Multicultural Clinical Setting: Embracing Mortality and Addressing Misperceptions of Vulnerability. Current oncology (Toronto, Ont.) 31 (5) (2024)
Florence T H Wu, James T Topham, Chris J O'Callaghan, Harriet E Feilotter, Hagen F Kennecke, Leylah Drusbosky, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Eric X Chen, Jonathan M Loree
Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo- RAS -Wildtype Metastatic Colorectal Cancer Is Transient. JCO precision oncology 8 (2024)
Heinz-Josef Lenz, Aparna Parikh, David R Spigel, Allen L Cohn, Takayuki Yoshino, Mark Kochenderfer, Elena Elez Fernandez, Spencer H Shao, Dustin Deming, Regan Holdridge, Timothy Larson, Eric X Chen, Amit Mahipal, Antonio Ucar, Dana Cullen, Edwina Baskin-Bey, Tong Kang, Amy B Hammell, Jin Yao, Josep Tabernero
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial. Journal for immunotherapy of cancer 12 (3) (2024)
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Joseph Walton, Angel S N Ng, Karen Arevalo, Anthony Apostoli, Jalna Meens, Christina Karamboulas, Jonathan St-Germain, Panagiotis Prinos, Julia Dmytryshyn, Eric X Chen, Cheryl H Arrowsmith, Brian Raught, Laurie Ailles
PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma. Nature communications 15 (1) (2024)
Heinz-Josef Lenz, Aparna Parikh, David R Spigel, Allen L Cohn, Takayuki Yoshino, Mark Kochenderfer, Elena Elez Fernandez, Spencer H Shao, Dustin Deming, Regan Holdridge, Timothy Larson, Eric X Chen, Amit Mahipal, Antonio Ucar, Dana Cullen, Edwina Baskin-Bey, Tong Kang, Amy B Hammell, Jin Yao, Josep Tabernero
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial. Journal for immunotherapy of cancer 12 (3) (2024)
Florence T H Wu, James T Topham, Chris J O'Callaghan, Harriet E Feilotter, Hagen F Kennecke, Leylah Drusbosky, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Eric X Chen, Jonathan M Loree
Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo- RAS -Wildtype Metastatic Colorectal Cancer Is Transient. JCO precision oncology 8 (2024)
Heinz-Josef Lenz, Aparna Parikh, David R Spigel, Allen L Cohn, Takayuki Yoshino, Mark Kochenderfer, Elena Elez Fernandez, Spencer H Shao, Dustin Deming, Regan Holdridge, Timothy Larson, Eric X Chen, Amit Mahipal, Antonio Ucar, Dana Cullen, Edwina Baskin-Bey, Tong Kang, Amy B Hammell, Jin Yao, Josep Tabernero
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial. Journal for immunotherapy of cancer 12 (3) (2024)
Heinz-Josef Lenz, Aparna Parikh, David R Spigel, Allen L Cohn, Takayuki Yoshino, Mark Kochenderfer, Elena Elez Fernandez, Spencer H Shao, Dustin Deming, Regan Holdridge, Timothy Larson, Eric X Chen, Amit Mahipal, Antonio Ucar, Dana Cullen, Edwina Baskin-Bey, Tong Kang, Amy B Hammell, Jin Yao, Josep Tabernero
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial. Journal for immunotherapy of cancer 12 (3) (2024)
Heinz-Josef Lenz, Aparna Parikh, David R Spigel, Allen L Cohn, Takayuki Yoshino, Mark Kochenderfer, Elena Elez Fernandez, Spencer H Shao, Dustin Deming, Regan Holdridge, Timothy Larson, Eric X Chen, Amit Mahipal, Antonio Ucar, Dana Cullen, Edwina Baskin-Bey, Tong Kang, Amy B Hammell, Jin Yao, Josep Tabernero
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial. Journal for immunotherapy of cancer 12 (3) (2024)
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Yvonne W Leung, Enid W Y Kwong, Karen Lok Yi Wong, Jeremiah So, Frankie Poon, Terry Cheng, Eric X Chen, Alex Molassiotis, Doris Howell
Understanding Elderly Chinese Cancer Patients in a Multicultural Clinical Setting: Embracing Mortality and Addressing Misperceptions of Vulnerability. Current oncology (Toronto, Ont.) 31 (5) (2024)
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus tissue tumor mutational burden as biomarkers of durvalumab plus tremelimumab response in patients with metastatic colorectal cancer in the CO.26 trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Cha Len Lee, Grainne M O'Kane, Warren P Mason, Wen-Jiang Zhang, Pavlina Spiliopoulou, Aaron Richard Hansen, Robert C Grant, Jennifer J Knox, Tracy L Stockley, Gelareh Zadeh, Eric X Chen
Circulating oncometabolite 2-hydroxyglutarate (2HG) as a potential biomarker for isocitrate dehydrogenase (IDH1/2) mutant cholangiocarcinoma. Molecular cancer therapeutics (2023)
Laith Al-Showbaki, Fahad A Almugbel, Husam A Alqaisi, Eitan Amir, Eric X Chen
Optimism Bias in the Design of Phase III Randomized Control Trials Evaluating PD-1/PD-L1 Targeting Monoclonal Antibodies. The oncologist 27 (6) (2022)
Geoffrey Alan Watson, Enrique Sanz-Garcia, Wen-Jiang Zhang, Zhihui Amy Liu, Sy Cindy Yang, Ben Wang, Shaofeng Liu, Shawn Kubli, Hal Berman, Thomas Pfister, Sofia Genta, Anna Spreafico, Aaron R Hansen, Philippe L Bedard, Stéphanie Lheureux, Albiruni Abdul Razak, Dave Cescon, Marcus O Butler, Wei Xu, Tak W Mak, Lillian L Siu, Eric X Chen
Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab. Journal for immunotherapy of cancer 10 (6) (2022)
Stefano Marastoni, Ainhoa Madariaga, Aleksandra Pesic, Sree Narayanan Nair, Zhu Juan Li, Zvi Shalev, Troy Ketela, Ilaria Colombo, Victoria Mandilaras, Michael Cabanero, Jeffrey P Bruce, Xuan Li, Swati Garg, Lisa Wang, Eric X Chen, Sarbjot Gill, Neesha C Dhani, Wenjiang Zhang, Melania Pintilie, Valerie Bowering, Marianne Koritzinsky, Robert Rottapel, Bradly G Wouters, Amit M Oza, Anthony M Joshua, Stephanie Lheureux
Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer. Cancer research communications 2 (5) (2022)
Stefano Marastoni, Ainhoa Madariaga, Aleksandra Pesic, Sree Narayanan Nair, Zhu Juan Li, Zvi Shalev, Troy Ketela, Ilaria Colombo, Victoria Mandilaras, Michael Cabanero, Jeffrey P Bruce, Xuan Li, Swati Garg, Lisa Wang, Eric X Chen, Sarbjot Gill, Neesha C Dhani, Wenjiang Zhang, Melania Pintilie, Valerie Bowering, Marianne Koritzinsky, Robert Rottapel, Bradly G Wouters, Amit M Oza, Anthony M Joshua, Stephanie Lheureux
Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer. Cancer research communications 2 (5) (2022)
James T Topham, Chris J O'Callaghan, Harriet Feilotter, Hagen F Kennecke, Young S Lee, Weimin Li, Kimberly C Banks, Katie Quinn, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Eric X Chen, Jonathan M Loree
Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Yanshuo Cao, Qing Chang, Michael Cabanero, Wenjiang Zhang, Sara Hafezi-Bakhtiari, David Hedley, Gail Darling, Fayez Quereshy, Raymond Jang, Elena Elimova, Jennifer Knox, Olga Ornatsky, Stefano Serra, Eric X Chen
Tumor Platinum Concentrations and Pathological Responses Following Cisplatin-Containing Chemotherapy in Gastric Cancer Patients. Journal of gastrointestinal cancer 50 (4) (2020)